UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 30, 2022 4:05 P.M.

Form:	F-3
CIK: 0001601936 Company Name: Altamira Therapeutics Ltd. File Number: 333-267584